Voluntary Benefits

Fifty-four percent of workers would give up at least one workplace perk for employer-covered GLP-1 treatment.

For employers' health plans, the new ATTR-CM specialty drugs could cost $500,000 per participant treated.

The move might, or might not, affect employers that fail to offer enough affordable major medical coverage.

The Idaho Farm Bureau Federation asked EBSA to assess a health coverage purchasing strategy it has proposed for its 10,770 members.

Renaissance CEO Diana Steinoff talks about how to sort from upselling from what workers really need to hear.

Officials from the department's benefits arm will also talk about COBRA.